Latest News

Imprint of chemotherapy linked to inflammation in breast cancer survivors

Chemotherapy can leave a long-lasting epigenetic imprint in the DNA of breast cancer patients' blood cells. That imprint is associated with biological signs of inflammation up to six months after the completion of treatment, and many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended. Now researchers have found clues that may explain how these symptoms can linger.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Mouse model provides window into working brain

  • Plain cigarette packs don't hurt small retailers or boost trade in illicit tobacco

  • High dietary salt may worsen multiple sclerosis symptoms

  • How Alzheimer's peptides shut down cellular powerhouses

  • Real tremors, or drug-seeking patient? New app can tell

  • Memory and Alzheimer's: Towards a better comprehension of the dynamic mechanisms

  • Nucleotide change could initiate Fragile X Syndrome

  • Childhood trauma could lead to adult obesity

  • Mechanical ventilation a key indicator for Pre-Term Children's maths problems

  • Risk of diabetes in children, adolescents exposed to antipsychotics: Danish 12-year case-control study

  •